US Oncology - Texas Oncology Austin Midtown — Austin, Texas

US Oncology - Texas Oncology Austin Midtown is a clinical research site located in Austin, Texas, United States 78705.

Crixeo Clinical Trials Trust Score: 6/100 (FAILING). This profile has not yet been claimed by the site owner.

US Oncology - Texas Oncology Austin Midtown has participated in 2 clinical trials.

Therapeutic areas: Myelodysplastic Syndromes (MDS), Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Sponsors: Sumitomo Pharma America, Inc., Karyopharm Therapeutics Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Austin

Browse all research sites in Texas · View every site in Austin

• Central Texas Spine Institute, Northwest Hills Surgical Hospital
• The University of Texas System Population Health
• Texas Oncology-Dallas Presbyterian Hospital
• St. David's Medical Center, Rehabilitation Hospital
• The University of Texas at Austin, Cardiovascular Aging Research Laboratory
• University of Texas at Austin Dell Medical School
• The University of Texas at Austin Dell Medical School Ascension Medical Group
• Hospital Physicians in Clinical Research
• Austin Heart Central at the Heart Hospital of Austin
• Steve Hicks School of Social Work, University of Texas at Austin
• University Medical Center Brackenridge
• University of Texas at Austin School of Nursing

Sponsor Feasibility Report

Trust Score: 6/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology - Texas Oncology Austin Midtown?

US Oncology - Texas Oncology Austin Midtown has a Crixeo Trust Score of 6/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology - Texas Oncology Austin Midtown conducted?

US Oncology - Texas Oncology Austin Midtown has 2 clinical trials on record. Their work covers Myelodysplastic Syndromes (MDS), Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Is US Oncology - Texas Oncology Austin Midtown accredited by Crixeo Clinical Trials?

US Oncology - Texas Oncology Austin Midtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology - Texas Oncology Austin Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.